Insider Shareholders with Direct Ownership of Vista Gen Therapeutics, Inc. (VTGN)
This section provides a comprehensive overview of the insiders with direct ownership of Vista Gen Therapeutics, Inc. (VTGN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
VistaGen Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 100,000 | 0 | 100,000 $269,000 | 1 |
Aug 18, 2022
Added 50.0%
|
|
|
H. Ralph Snodgrass
PRES./CHIEF SCIENTIFIC OFFICER |
13,125 | 0 | 64,958 $174,737 | 4 |
Dec 31, 2021
Added 5.28%
|
|
Mark Alan Smith
CHIEF MEDICAL OFFICER |
14,915 | 0 | 19,915 $53,571 | 4 |
Jun 30, 2022
Added 20.07%
|
|
Reid G. Adler
CHF CORP DEVEL OFF, GEN COUNS |
305,188 | 0 | 16,509 $44,409 | 4 |
Jun 28, 2024
Added 22.72%
|
|
Shawn Singh
CHIEF EXECUTIVE OFFICER |
133,811 | 0 | 10,487 $28,210 | 10 |
Jun 28, 2024
Added 31.64%
|
| 2,500 | 0 | 5,751 $15,470 | 1 |
Mar 19, 2021
Added 30.3%
|
|
|
Jerrold Duane Dotson
VP, CFO |
130,278 | 30,000 | 3,671 $9,874 | 8 |
Jun 30, 2023
Added 4.35%
|
|
Cynthia Lynn Anderson
CHIEF FINANCIAL OFFICER |
3,592 | 0 | 3,592 $9,662 | 1 |
Jun 28, 2024
Added 50.0%
|
|
Joshua S. Prince
Chief Operating Officer |
2,671 | 0 | 2,671 $7,184 | 1 |
Jun 28, 2024
Added 50.0%
|
| 2,500 | 0 | 2,500 $6,725 | 1 |
Mar 19, 2021
Added 50.0%
|